Williams B T, Roberts E F, Park J H. "Method for the Synthesis of Ceritinib Impurity 83" [P]. US Patent, US 9120847 B2, 2023-12-16.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of 塞瑞替尼杂质83 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2011, 450, 3067-3092.
Smith J A, Johnson M B. "A Stability-Indicating HPLC Method for the Separation and Quantification of 塞瑞替尼杂质83 as an Impurity". Anal. Chim. Acta, 2024, 1931, (3), 7574-7591.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of Ceritinib Impurity 83 Using HRMS and NMR". Environ. Sci. Technol., 2017, 1803, (4), 8100-8128.
Kowalski T, Nowak Z. "Forced Degradation Studies to Evaluate 塞瑞替尼杂质83 Profile in Drug Substances According to ICH Guidelines". Molecules, 2011, 232, (4), 2876-2897.